SARS-COV-2 and blood disorders
What are inhibitors?
For example factors VIII or IX clotting factors for hemophilia
Are patients with blood disorders at a higher risk?
Some patients with hemophilia may develop inhibitors and doctors may prescribe them immunosuppressants. These are medicines that suppress the immune system. They may, therefore, make patients more susceptible to infections including SARS-CoV-2.
Plasma therapy is safe from SARS-COV-2 pathogen transmission. Statement by HFA
PPTA Statement
WORLD FEDERATION OF HEMOPHILIA RECOMMENDATIONS FOR HEMOPHILIA PATIENTS
Pandemic and hemoglobin disorders
Sickle cell anemia
Cell sickling in the hypoxic and acidic environment leading to the acute chest syndrome. Plus carboxyamide is mild immunosuppressant that may results in additional risk.
Hemophilia and COVID-19
von Willebrand Disease and Hemophilia A
Hypercoagulopathy
Desmopressin (DDAVP)
G6PD deficiency and COVID-19
How I treat vWF disease
